Sanctuary Advisors LLC Decreases Stock Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Sanctuary Advisors LLC decreased its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 4.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,998 shares of the medical instruments supplier’s stock after selling 268 shares during the period. Sanctuary Advisors LLC’s holdings in Utah Medical Products were worth $392,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new stake in shares of Utah Medical Products during the third quarter valued at about $207,000. Barclays PLC boosted its holdings in Utah Medical Products by 214.1% in the third quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 3,118 shares during the last quarter. Geode Capital Management LLC grew its stake in Utah Medical Products by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier’s stock valued at $6,497,000 after purchasing an additional 8,516 shares in the last quarter. State Street Corp grew its stake in Utah Medical Products by 0.9% during the 3rd quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock valued at $5,434,000 after purchasing an additional 694 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC increased its holdings in Utah Medical Products by 128.3% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier’s stock worth $5,956,000 after purchasing an additional 50,030 shares during the last quarter. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Stock Performance

UTMD opened at $61.58 on Friday. The company has a market capitalization of $208.88 million, a P/E ratio of 14.42 and a beta of 0.08. The company has a 50-day moving average of $64.58 and a 200-day moving average of $66.44. Utah Medical Products, Inc. has a 1-year low of $60.39 and a 1-year high of $87.00.

Utah Medical Products Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be issued a $0.305 dividend. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 1.98%. The ex-dividend date is Monday, December 16th. Utah Medical Products’s payout ratio is currently 28.57%.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.